Mouse models for studies of HLA-G functions in basic science and pre-clinical research

被引:8
|
作者
Anh Thu Nguyen-Lefebvre [1 ]
Ajith, Ashwin [1 ]
Portik-Dobos, Vera [1 ]
Horuzsko, Daniel D. [1 ]
Mulloy, Laura L. [2 ]
Horuzsko, Anatolij [1 ,2 ]
机构
[1] Georgia Regents Univ, Ctr Canc, Mol Oncol & Biomarkers Program, 1140 Laney Walker Blvd, Augusta, GA 30912 USA
[2] Georgia Regents Univ, Dept Med, 1120 15th St, Augusta, GA 30912 USA
关键词
HLA-G; Transgenic mice; Humanized mice; Transplantation; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; CHORIOCARCINOMA CELL-LINE; DENDRITIC CELLS; HUMANIZED MICE; INHIBITORY RECEPTOR; TRANSGENIC MICE; MYELOMONOCYTIC CELLS; BIOMEDICAL-RESEARCH; T-LYMPHOCYTES;
D O I
10.1016/j.humimm.2016.02.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-G was described originally as a tolerogenic molecule that allows the semiallogeneic fetus to escape from recognition by the maternal immune response. This review will discuss different steps in the study of HLA-G expression and functions in vivo, starting with analyses of expression of the HLA-G gene and its receptors in transgenic mice, and continuing with applications of HLA-G and its receptors in prevention of allograft rejection, transplantation tolerance, and controlling the development of infection. Humanized mouse models have been discussed for developing in vivo studies of HLA-G in physiological and pathological conditions. Collectively, animal models provide an opportunity to evaluate the importance of the interaction between HLA-G and its receptors in terms of its ability to regulate immune responses during maternal-fetal tolerance, survival of allografts, tumor escape mechanisms, and development of infections when both HLA-G and its receptors are expressed. In addition, in vivo studies on HLA-G also offer novel approaches to achieve a reproducible transplantation tolerance and to develop personalized medicine to prevent allograft rejection. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:711 / 719
页数:9
相关论文
共 50 条
  • [41] The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies
    Sokolakis, Ioannis
    Dimitriadis, Fotios
    Teo, Pearline
    Hatzichristodoulou, Georgios
    Hatzichristou, Dimitrios
    Giuliano, Francois
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (02): : 168 - 194
  • [42] Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies
    Martiniello-Wilks, R
    Dane, A
    Mortensen, E
    Jeyakumar, G
    Wang, XY
    Russell, PJ
    ANTICANCER RESEARCH, 2003, 23 (3B) : 2633 - 2642
  • [43] Pre-clinical studies in remote ischaemic conditioning: a solid foundation for on-going clinical research?
    Garcia-Dorado, David
    CARDIOVASCULAR RESEARCH, 2017, 113 (03) : 251 - 253
  • [44] Our Inner Mouse: Genomic Insights from Mouse Mammary Cancer Models To Guide Pre-clinical Testing
    Green, J. E.
    CANCER RESEARCH, 2009, 69 (24) : 483S - 483S
  • [45] How do we select meaningful pre-clinical models for studies in radiation biology?
    De Ruysscher, D.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S239 - S240
  • [46] Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models
    Shue, Yan Ting
    Lim, Jing Shan
    Sage, Julien
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (01) : 21 - 31
  • [47] Developing standard procedures for pre-clinical efficacy studies in mouse models of spinal muscular atrophy Report of the expert workshop "Pre-clinical testing for SMA", Zurich, March 29-30th 2010
    Willmann, Raffaella
    Dubach, Judith
    Chen, Karen
    NEUROMUSCULAR DISORDERS, 2011, 21 (01) : 74 - 77
  • [48] HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies
    Zanotti, Ilaria
    Poti, Francesco
    Cuchel, Marina
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2022, 1867 (01):
  • [49] Signaling plasticity in pre-clinical models of resistance to KRAS-G12C inhibitors
    Ambrogio, Chiara
    CANCER SCIENCE, 2024, 115 : 1738 - 1738
  • [50] Humanized mouse models of KRAS-mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies
    Davola, Maria E.
    Cormier, Olga
    Lepard, Madeleine
    Mcnicol, Jamie
    Collins, Susan
    Hammill, Joanne A.
    Silvestri, Christopher
    Bramson, Jonathan L.
    Gillgrass, Amy
    Mossman, Karen L.
    ONCOIMMUNOLOGY, 2025, 14 (01):